All In Biotech

Drug Trial Radar · NCT00003578

High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

A Randomized Trial to Evaluate Early High Dose Therapy and Autologous Bone Marrow Transplantation as Part of Planned Initial Therapy for Poor Risk Intermediate/High Grade NHL

Last checked: Nov 20, 2026Latest source record: Sep 20, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

500

Planned (sponsor's estimate)

Start

Jan 1993

Primary completion

Not stated

Sponsor

Lead sponsor
Lymphoma Trials OfficeAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 27, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Primary purpose
Treatment
Who can join
All sexes, from 16 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Bone marrow transplantation may allow doctors to give higher doses of chemotherapy drugs and kill more cancer cells. It is not yet known whether high dose chemotherapy plus bone marrow transplantation is more effective than high dose chemotherapy alone for intermediate- or high-grade non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to compare the effectiveness of high dose chemotherapy with or without bone marrow transplantation in treating patients who have intermediate- or high-grade non-Hodgkin's lymphoma.

Conditions

  • Lymphoma

Interventions

  • CHOP regimenDrug

  • carmustineDrug

  • cyclophosphamideDrug

  • cytarabineDrug

  • doxorubicin hydrochlorideDrug

  • etoposideDrug

  • melphalanDrug

  • prednisoneDrug

  • vincristine sulfateDrug

  • autologous bone marrow transplantationProcedure

  • peripheral blood stem cell transplantationProcedure

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

72 sites in 4 countries. Site status is shown where the registry gives one.

  • Charles University Hospital

    Prague (Praha), Czechia

  • Aarhus Amtssygehus

    Aarhus, Denmark

  • Rigshospitalet

    Copenhagen, Denmark

  • Norwegian Radium Hospital

    Oslo, Norway

  • Ullevall Hospital

    Oslo, Norway

  • University of Tromso

    Tromsø, Norway

  • Royal Bournemouth Hospital

    Bournemouth, United Kingdom

  • Law Hospital

    Carluke UK, United Kingdom

  • Saint Richards Hospital

    Chichester, United Kingdom

  • Chase Farm Hospital

    Enfield, United Kingdom

  • Epsom General Hospital

    Epsom Surrey, United Kingdom

  • Grantham and District Hospital

    Grantham, United Kingdom

  • King George Hospital

    Ilford, Essex, United Kingdom

  • Queen Elizabeth Hospital

    Kings Lynn, United Kingdom

  • Walton General Hospital

    Liverpool, United Kingdom

  • Newham General Hospital

    London, United Kingdom

  • St. Mary's Hospital

    London, United Kingdom

  • West Middlesex Hospital

    Middlesex, United Kingdom

  • East Surrey Hospital

    Redhill, United Kingdom

  • Rotherham District General Hospital-NHS Trust

    Rotherham, United Kingdom

  • Scunthorpe General Hospital

    Scunthorpe, United Kingdom

  • Staffordshire General Hospital

    Stafford, United Kingdom

  • Stoke Mandeville Hospital

    Aylesbury-Buckinghamshire, England, United Kingdom

  • Royal United Hospital

    Bath, England, United Kingdom

  • City Hospital - Birmingham

    Birmingham, England, United Kingdom

  • Birmingham Heartlands and Solihull NHS Trust (Teaching)

    Birmingham, England, United Kingdom

  • Southmead Hospital

    Bristol, England, United Kingdom

  • Bristol Haematology and Oncology Centre

    Bristol, England, United Kingdom

  • Queen's Hospital, Burton

    Burton-on-Trent, England, United Kingdom

  • Kent and Canterbury Hospital

    Canterbury, England, United Kingdom

  • Cheltenham General Hospital

    Cheltenham, England, United Kingdom

  • Countess of Chester Hospital

    Chester, England, United Kingdom

  • Derbyshire Royal Infirmary

    Derby, England, United Kingdom

  • Royal Free Hospital

    Hampstead, London, England, United Kingdom

  • Northwick Park Hospital

    Harrow, England, United Kingdom

  • Huddersfield Royal Infirmary

    Huddersfield, West Yorks, England, United Kingdom

  • Ipswich Hospital NHS Trust

    Ipswich, England, United Kingdom

  • Leeds Teaching Hospital Trust

    Leeds, England, United Kingdom

  • University Hospitals of Leicester

    Leicester, England, United Kingdom

  • Royal Liverpool and Broadgreen Hospitals

    Liverpool, England, United Kingdom

Showing 40 of 72 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.